Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
Open Access
- 19 August 1999
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 58 (7) , 1097-1107
- https://doi.org/10.1016/s0006-2952(99)00200-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- p53, bcl-2 and Retinoblastoma Proteins as Long-Term Prognostic Markers in Localized Carcinoma of the ProstateJournal of Urology, 1997
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- SHORT COMMUNICATION: Sulindac suppresses tumorigenesis in the Min mouseCarcinogenesis: Integrative Cancer Research, 1996
- The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposisGastroenterology, 1995
- The Functional Basis of c-myc and bcl-2 Complementation during Multistep Lymphomagenesis in VivoExperimental Cell Research, 1995
- Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?Journal of Cellular Biochemistry, 1995
- Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3Cell, 1993
- A protective effect of sulindac against chemically‐induced primary colonic tumours in miceThe Journal of Pathology, 1988
- Sulindac for polyposis of the colonJournal of Surgical Oncology, 1983
- Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomachJournal of Surgical Oncology, 1983